MedTrace Logo

Skeletal Fragility in Type 1 Diabetes: Glycemic Control and Bone Strength

NCT04289727 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 86

Last updated 2026-02-02

No results posted yet for this study

Summary

The purpose of this research study is to find out how bones are affected in children and adolescents with type 1 diabetes (T1D) as compared to children and adolescents without type 1 diabetes.

Conditions

  • Type1diabetes

Sponsors & Collaborators

  • National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

    collaborator NIH

  • Columbia University

    lead OTHER

Principal Investigators

  • Mishaela Rubin, MD · Columbia University

Eligibility

Min Age
8 Years
Max Age
14 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-01-01
Primary Completion
2025-09-08
Completion
2025-09-08

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04289727 on ClinicalTrials.gov